(Q27261317)

UNII-55MOB566V7 (English)

14 October 2016

chemical formula

C₂₁H₂₄F₃N₃O₄

1 reference

UNII-55MOB566V7 (English)

14 October 2016

canonical SMILES

COC1=C2C(=CC(=C1N3CC(C(C3)F)CNC4CC4)F)C(=O)C(=CN2CCF)C(=O)O

1 reference

UNII-55MOB566V7 (English)

14 October 2016

isomeric SMILES

COC1=C2C(=CC(=C1N3C[C@@H]([C@@H](C3)F)CNC4CC4)F)C(=O)C(=CN2CCF)C(=O)O

1 reference

UNII-55MOB566V7 (English)

https://www.whocc.no/atc_ddd_index/?code=J01MA25

14 October 2016

defined daily dose

75 milligram

route of administration

oral administration

1 reference

reference URL

‎WHO Aware Classification

watch

1 reference

stated in

2023 ‎AWaRe classification‎

Identifiers

InChI

InChI=1S/C21H24F3N3O4/c1-31-20-17-13(19(28)14(21(29)30)9-26(17)5-4-22)6-15(23)18(20)27-8-11(16(24)10-27)7-25-12-2-3-12/h6,9,11-12,16,25H,2-5,7-8,10H2,1H3,(H,29,30)/t11-,16+/m0/s1

1 reference

UNII-55MOB566V7 (English)

14 October 2016

1 reference

Global Substance Registration System

UNII-55MOB566V7 (English)

14 October 2016

1 reference

UNII

55MOB566V7

lascufloxacin (English)

14 October 2016

1 reference

Lascufloxacin (English)

14 October 2016

2 references

UNII-55MOB566V7 (English)

matched by identifier from

14 October 2016

matched by identifier from

1 reference

1 reference

https://www.whocc.no/atc_ddd_index/?code=J01MA25

ATC code

J01MA25

1 reference

reference URL

Guide to Pharmacology Ligand ID

10823

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

5 February 2021

2 references

Global Substance Registration System

UNII

55MOB566V7

lascufloxacin (English)

matched by identifier from

14 October 2016